US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted A61KA61K31/5383A61P
Quick answer
US patent 12264167 (Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors) held by NIKANG THERAPEUTICS, INC. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NIKANG THERAPEUTICS, INC.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/5383, A61P, A61P35/00